Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Lexeo Therapeutics
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
June 15, 2026
Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 19, 2026
Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights
May 11, 2026
Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 27, 2026
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
March 30, 2026